Companies related to immunooncology

Pioneers in Automated Cell Counting and Analysis

Harnessing more of the immune system for better cancer outcomes

Pioneers in Cell Therapy ASX:CHM

Agility. Flexibility. Reliability.

Reshaping the future of immunotherapies

Great Minds Think Ignyte

Engineering the Next Generation of Therapeutics

Reimagining medicine by transforming cancer

Developing allogeneic TCR-NK therapies for solid tumors

Accelerating drug development with integrated multimodal AI

Reimaging Cancer Immunotherapy

Improving therapeutic performance for predictive clinical outcomes through in vitro microenvironment control.

Pioneering the next generation of precision medicines to deliver a portfolio of transformative cancer therapies.

Next generation cell therapies for ALK-positive cancer patients